GB:4BB Stock Latest News
Company Announcements4basebio Raises £15m Through Retail Offer and Share Issue1w ago
Company Announcements4basebio Calls Shareholder Vote on Capital Raise to Support Synthetic DNA Growth1w ago
Company Announcements4basebio Launches Retail Offer to Extend Cash Runway and Fund Growth2w ago
Company Announcements4basebio secures £15m conditional capital raise and restructures shareholder loan2w ago
Company Announcements4basebio Launches £15m Share Issue to Fuel Genomic Medicine Growth2w ago
Company Announcements4basebio Pipeline Surges as Synthetic DNA Demand Builds Despite Lower First-Half Revenue1M ago
Company Announcements4basebio Strikes Genezen Pact to Advance Synthetic DNA for Viral Vector Manufacturing2M ago
Company Announcements4basebio awards new management share options to support long-term growth3M ago
Company Announcements4basebio strengthens board with deep tech investor Cornel Chiriac3M ago
Company Announcements4basebio Secures AGM Backing and Awards New Employee Share Options4M ago
Company Announcements4basebio Sets Investor Presentation as It Advances Synthetic DNA Platform4M ago
Company Announcements4basebio ramps up commercial push as revenue surges and GMP wins fuel synthetic DNA growth5M ago
Company Announcements4basebio Secures Seven-Figure Clinical Supply Deal for Phase II Immunotherapy Trial5M ago- Company Announcements4basebio strengthens leadership with new CFO and board reshuffle5M ago
- Company Announcements4basebio Leases New Cambridge Facility to Scale Synthetic DNA Manufacturing7M ago
Company Announcements4basebio Appoints COO to Drive Synthetic DNA Scale-Up and Commercial Growth7M ago
Company Announcements4basebio bolsters commercial leadership to drive synthetic DNA growth8M ago